Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1401385

	registered interest
	date	10/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether covid-19 lateral flow test products that are made in the UK for use in the UK are subject to (a) testing or (b) checking requirements that are (i) different or (ii) in addition to those applied to covid-19 lateral flow test products manufactured in the Far East for use in the UK.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	100450
	answer	answer is ministerial correction date of answer 26/01/2022 answer text <p>All COVID-19 lateral flow test devices and their manufacturers are subject to the Medical Device Regulations 2002 and COVID Testing Devices Authorisation requirements regardless of the origin of manufacture. There are no alternative or additional requirements for devices manufactured in the United Kingdom.</p><p>In exceptional circumstances, the Medicines and Healthcare products Regulatory Agency (MHRA) can issue an Exceptional Use Authorisation (EUA). The MHRA publishes the names of tests and other medical devices which have been granted an EUA online. All manufacturers are subject to the same EUA assessment standards regardless of the location of the manufacturer.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 26/01/2022 17:02:55 answering member 4447 label Biography information for Maggie Throup previous answer version 43171 answering member constituency Erewash answering member printed Maggie Throup answering member 4447 label Biography information for Maggie Throup
	tabling member	1409 label Biography information for Mr Gregory Campbell

1548333

	registered interest
	date	05/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Streptococcus: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he expects the Group B Strep trial to report before early 2025.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	102798
	answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations is expected to end on 31 May 2024 and findings will be reported following a full analysis of the trial data.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/12/2022 12:08:22 answering member 4423 label Biography information for Will Quince previous answer version 40779 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	1409 label Biography information for Mr Gregory Campbell

1244011

	registered interest
	date	15/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether it remains his policy increase diagnosis of the 10 most common cancers at stages 1 and 2 to 75 percent by 2028.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	104062
	answer	answer is ministerial correction date of answer 11/11/2020 answer text <p>The NHS Long Term Plan commitments remain in place despite the COVID-19 pandemic. This includes the commitment of staging 75% of all cancers at stage 1 or 2.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 11/11/2020 13:27:42 answering member 4380 label Biography information for Jo Churchill previous answer version 55753 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1668829

	registered interest
	date	09/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether there have been any instances of unauthorised parties gaining access to (a) sensitive data and (b) confidential information stored on the Federated Data Platform in the last 12 months.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	1045
	answer	answer is ministerial correction date of answer 22/11/2023 answer text <p>The Federated Data Platform (FDP) is software that will sit across National Health Service trusts and integrated care systems allowing them to connect data they already hold in a secure and safe environment.</p><p>NHS England announced the outcome of the tender for the FDP on Tuesday 21 November. The service is not yet live or in use. In line with current transition planning, we do not expect data to be placed into the FDP until 2024.</p><p>No unauthorised parties have gained access to sensitive data or confidential information for the Care Coordination Solution or OPTICA pilots, which have been testing and demonstrating the kinds of benefits which the FDP is expected to deliver.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/11/2023 16:42:40 answering member 4044 label Biography information for Andrew Stephenson previous answer version 1014 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1409 label Biography information for Mr Gregory Campbell

1244174

	registered interest
	date	16/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: European Reference Networks
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent progress the Government has made with the European Commission on the UK's relationship with the European Reference Network for rare diseases after the transition period.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	104699
	answer	answer is ministerial correction date of answer 04/11/2020 answer text <p>Continued United Kingdom membership of the European Reference Networks beyond the end of 2020 remains subject to the outcome of negotiations with the European Commission. The European Reference Networks are not negotiated in isolation and instead form part of a complex set of interlinked policy issues that remain subject to ongoing negotiations with the European Union.</p><p>As part of the UK Strategy for Rare Diseases the Government has supported world-leading experts in rare diseases through clinical services and research. We remain committed to improving the diagnosis and treatment of rare disease patients through the new UK Rare Disease Framework, set to be published by the end of 2020, and the Genome UK strategy. Additionally, UK clinicians across all four nations have been asked to advise the Government on which elements should be retained if future participation in the ERNs is not agreed.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/11/2020 11:09:19 answering member 4380 label Biography information for Jo Churchill previous answer version 56048 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1244158

	registered interest
	date	16/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Ultrasonics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to support the development of the evidence base for high-intensity focused ultrasound therapy for prostate cancer.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	104700
	answer	answer is ministerial correction date of answer 27/10/2020 answer text <p>The National Institute for Health Research has funded, and supported, several research studies on high-intensity focused ultrasound (HIFU) therapy for prostate cancer over the last five years. This includes an award of £677,000 for the feasibility of a randomised controlled trial of partial prostate ablation (via HIFU) versus radical prostatectomy in intermediate risk unilateral clinically localised prostate cancer.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 27/10/2020 12:41:47 answering member 4362 label Biography information for Edward Argar previous answer version 56049 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1244709

	registered interest
	date	19/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Children: Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has undertaken a ten year review of the outcomes of the Change4Life programme.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	105296
	answer	answer is ministerial correction date of answer 29/10/2020 answer text <p>A 10-year review of the outcomes of the Change4Life programme has not been undertaken.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/10/2020 11:45:27 answering member 4380 label Biography information for Jo Churchill previous answer version 56511 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1683622

	registered interest
	date	19/01/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Processed Food: Sugar
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will hold discussions with the food industry on reducing the sugar content in (a) food and (b) drink products.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	10596
	answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>As she has done in previous ministerial roles, the current Secretary of State will recuse herself on departmental issues relating to outside interests, all of which have been declared to the House and under the Ministerial Code.</p><p>Discussions have been held with businesses by the Minister for Public Health, and officials, since 2015, on the actions they can take to reduce the sugar content of food and drink products.</p><p>The Soft Drinks Industry Levy (SDIL) came in to force in April 2018. Between 2015 and 2020, levels of sugar in drinks subject to SDIL reduced by 46%, removing over 45,000 tonnes of sugar, while sales increased by approximately 21%. The reductions were spread evenly across all socio-economic groups.</p><p>Milk based drinks are excluded from the levy but are included in the voluntary sugar reduction programme. To date, sugar and calories in pre-packed milk based drinks sold through retail have reduced by 29.7% and 20%, respectively. Pre-packed milk substitute drinks have reduced sugar and calories by 6.9% and 8%, respectively.</p><p>The voluntary sugar reduction programme also includes the foods that contribute most to the sugar intakes of children aged up to 18 years old. Between 2015 and 2020, reductions in sugar levels were seen in all categories, with breakfast cereals and yogurts and fromage frais showing the greatest change with reductions of 14.9% and 13.5%, respectively, and removing 21,960 tonnes of sugar.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 24/01/2024 17:37:57 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	1409 label Biography information for Mr Gregory Campbell

1245599

	registered interest
	date	21/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Shortages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps have been taken to prepare for the supply of medicine stocks from Great Britain to Northern Ireland (a) before and (b) after 1 January 2021.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	106906
	answer	answer is ministerial correction date of answer 05/11/2020 answer text <p>The Department, in consultation with the devolved administrations and Crown Dependencies, is working with trade bodies, product suppliers, and the health and care system to make detailed plans to help ensure continued supply of medicines and medical products to the whole of the United Kingdom, including Northern Ireland, at the end of the transition period, and will continue to after the end of the transition period.</p><p>This includes:</p><p>- medicines (prescription-only, pharmacy and general sales list and unlicensed medicines);</p><p>- medical devices and clinical consumables;</p><p>- supplies for clinical trials and clinical investigations;</p><p>- vaccines and countermeasures; and</p><p>- blood, tissue and transplant materials.</p><p> </p><p>Further detail on the plans to help ensure continuity of medical supplies is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/letter-to-medicines-and-medical-products-suppliers-3-august-2020/letter-to-medicine-suppliers-3-august-2020" target="_blank">https://www.gov.uk/government/publications/letter-to-medicines-and-medical-products-suppliers-3-august-2020/letter-to-medicine-suppliers-3-august-2020</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2020 13:41:38 answering member 4380 label Biography information for Jo Churchill previous answer version 58260 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1404328

	registered interest
	date	19/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: South Africa
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will have discussions, alongside Cabinet colleagues, with the South African authorities to establish whether the latest official WHO figures which indicate an 80 per cent reduction in new cases of covid-19 within the last month are accurate.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	107477
	answer	answer is ministerial correction date of answer 03/03/2022 answer text <p>There are no plans to do so. The UK Health Security Agency does not review the accuracy of official World Health Organization (WHO) data from other countries. The Government continues to engage with South African colleagues and other international partners such as the WHO, foreign ministries and public health laboratories to enable data sharing and strengthen global surveillance.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 03/03/2022 09:43:14 answering member 4447 label Biography information for Maggie Throup previous answer version 45797 answering member constituency Erewash answering member printed Maggie Throup answering member 4447 label Biography information for Maggie Throup
	tabling member	1409 label Biography information for Mr Gregory Campbell